Iron Chelation with Deferasirox in Two Patients with HFE Hemochromatosis and Chronic Anemia | Citedby Results | Acta Haematologica | Karger Publishers

Skip to Main Content

Skip Nav Destination

Iron Chelation with Deferasirox in Two Patients with HFE Hemochromatosis and Chronic Anemia

Acta Haematol (2011) 126 (2): 119–121.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Chelation therapy in liver diseases of childhood: Current status and response

Jayendra Seetharaman
Moinak Sen Sarma

World Journal of Hepatology (2021) 13 (11): 1552.

Juvenile Hemochromatosis: Rheumatic Manifestations of 2 Sisters Responding to Deferasirox Treatment. A Case Series and Literature Review

Jubran Alqanatish
Banan Alsowailmi
Haneen Alfarhan
Albandari Alhamzah
Talal Alharbi

Open Access Rheumatology: Research and Reviews (2021) Volume 13: 15.

ACG Clinical Guideline: Hereditary Hemochromatosis

Kris V. Kowdley
Kyle E. Brown
Joseph Ahn
Vinay Sundaram

American Journal of Gastroenterology (2019) 114 (8): 1202.

How we manage patients with hereditary haemochromatosis

Eva Rombout‐Sestrienkova
Marian G. J. van Kraaij
Ger H. Koek

British Journal of Haematology (2016) 175 (5): 759.

Deferasirox in patients with iron overload secondary to hereditary hemochromatosis: results of a 1‐yr Phase 2 study

Rodolfo Cançado
Murilo R. Melo
Roberto de Moraes Bastos
Paulo C. J. L. Santos
Elivira M. Guerra‐Shinohara
Carlos Chiattone
Samir K. Ballas

European Journal of Haematology (2015) 95 (6): 545.